|. Reports, , vol.9, 2019.

N. Murphy, Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study, Clin Gastroenterol Hepatol, 2018.

F. Bray, Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin, 2018.

T. Landre, Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis, Int J Colorectal Dis, vol.30, pp.1305-1310, 2015.

I. Mármol, C. Sánchez-de-diego, A. Pradilla-dieste, E. Cerrada, and M. Rodriguez-yoldi, Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer, Int J Mol Sci, vol.18, p.197, 2017.

, ScIenTIfIc RePoRTs |, vol.9, 2019.

E. M. Webber, T. L. Kauffman, E. O'connor, and K. A. Goddard, Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy, BMC Cancer, vol.15, p.156, 2015.

T. Xie, MicroRNAs as Regulators, Biomarkers and Therapeutic Targets in the Drug Resistance of Colorectal Cancer, Cell Physiol Biochem, vol.40, pp.62-76, 2016.

Y. Touil, Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis, Clin Cancer Res, vol.20, pp.837-846, 2014.

V. S. Jones, Cytokines in cancer drug resistance: Cues to new therapeutic strategies, Biochim Biophys Acta -Rev Cancer, vol.1865, pp.255-265, 2016.

J. Tang, Y. Feng, X. Liang, and X. Cai, Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges, Chin Med J (Engl), vol.129, pp.456-63, 2016.

Y. Zheng, J. Zhou, and Y. Tong, Gene signatures of drug resistance predict patient survival in colorectal cancer, Pharmacogenomics J, vol.15, pp.135-178, 2015.

J. Deng, Y. Wang, J. Lei, W. Lei, and J. P. Xiong, Insights into the involvement of noncoding RNAs in 5-fluorouracil drug resistance, Tumor Biol, vol.39, p.101042831769755, 2017.

N. Zhang, Y. Yin, S. Xu, and W. Chen, 5-Fluorouracil: mechanisms of resistance and reversal strategies, Molecules, vol.13, pp.1551-69, 2008.

F. El-khoury, L. Corcos, S. Durand, B. Simon, and C. Le-jossic-corcos, Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells, Int J Oncol, vol.49, pp.2558-2568, 2016.

A. Kim, J. Kwak, N. K. Je, Y. Lee, and Y. Jung, Epithelial-mesenchymal Transition is Associated with Acquired Resistance to 5-Fluorocuracil in HT-29 Colon Cancer Cells, Toxicol Res, vol.31, pp.151-157, 2015.

Z. Jiang, Y. Sun, S. Wang, and J. Ruan, Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression, J Cancer, vol.8, pp.2319-2327, 2017.

A. González-sarrías, J. Tomé-carneiro, A. Bellesia, F. A. Tomás-barberán, and J. C. Espín, The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells, Food Funct, vol.6, pp.1460-1469, 2015.

A. Dayem and A. , The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms, Nutrients, vol.8, p.581, 2016.

M. S. Abaza, K. Y. Orabi, E. Al-quattan, and R. J. Al-attiyah, Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer, Cancer Cell Int, vol.15, p.46, 2015.

S. A. Hussain, Natural Polyphenols in Cancer Chemoresistance, Nutr Cancer, vol.68, pp.879-891, 2016.

T. Aung, Z. Qu, R. Kortschak, and D. Adelson, Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action, Int J Mol Sci, vol.18, p.656, 2017.

J. Lee, J. Kang, B. Choi, and Y. Keum, Sensitization of 5-Fluorouracil-Resistant SNUC5 Colon Cancer Cells to Apoptosis by ?-Mangostin, Biomol Ther (Seoul), vol.24, pp.604-609, 2016.

W. F. Taylor and E. Jabbarzadeh, The use of natural products to target cancer stem cells, Am J Cancer Res, vol.7, pp.1588-1605, 2017.

V. J. Findlay, SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression, Mol Cancer Ther, vol.13, pp.2713-2739, 2014.

S. Violette, Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status, Int J cancer, vol.98, pp.498-504, 2002.

I. Riahi-chebbi, Quince peel polyphenolic extract blocks human colon adenocarcinoma LS174 cell growth and potentiates 5-fluorouracil efficacy, Cancer Cell Int, vol.16, p.1, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01356545

M. Yaheya and M. Ismail, Review Article DRUG-FOOD INTERACTIONS AND ROLE OF PHARMACIST, Asian Journal of Pharmaceutical and Clinical Research, vol.2, pp.1-10, 2009.

K. Ijichi, M. Adachi, T. Ogawa, Y. Hasegawa, and S. Murakami, Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells, Anticancer Res, vol.34, pp.2907-2918, 2014.

M. Hassan, H. Watari, A. Abualmaaty, Y. Ohba, and N. Sakuragi, Apoptosis and Molecular Targeting Therapy in Cancer, Biomed Res Int, pp.1-23, 2014.

A. Y. Chen and Y. C. Chen, A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention, Food Chem, vol.138, pp.2099-2107, 2013.

C. Huang and L. C. Yu, Pathophysiological mechanisms of death resistance in colorectal carcinoma, World J Gastroenterol, vol.21, pp.11777-92, 2015.

V. Grossi, A. Peserico, T. Tezil, and C. Simone, p38? MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance, World J Gastroenterol, vol.20, p.9744, 2014.

Z. Wang, Broad targeting of angiogenesis for cancer prevention and therapy, Semin Cancer Biol, vol.35, pp.224-243, 2015.

K. Aubry, J. L. Labourey, J. P. Bessède, N. Tubiana-mathieu, and M. Rigaud, Expression levels of thymidylate synthase, thymidylate phosphorylase and dihydropyrimidine dehydrogenase in head and neck squamous cell carcinoma: preliminary study, Clin Med Oncol, vol.2, pp.27-35, 2008.

T. Liu, Y. Lin, X. Wen, R. N. Jorissen, and M. K. Gilson, BindingDB: a web-accessible database of experimentally determined proteinligand binding affinities, Nucleic Acids Res, vol.35, pp.198-201, 2007.

J. Phan, Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors, J Biol Chem, vol.276, pp.14170-14177, 2001.

M. Goettert, V. Schattel, P. Koch, I. Merfort, and S. Laufer, Biological Evaluation and Structural Determinants of p38? MitogenActivated-Protein Kinase and c-Jun-N-Terminal Kinase 3 Inhibition by Flavonoids, ChemBioChem, vol.11, pp.2579-2588, 2010.

N. Anreddy, Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance, Molecules, vol.19, pp.13848-13877, 2014.

J. Cao, J. Han, H. Xiao, J. Qiao, and M. Han, Effect of Tea Polyphenol Compounds on, Anticancer Drugs in Terms of Anti-Tumor Activity, vol.8, 2016.

D. Van-dijk, Slow-growing cells within isogenic populations have increased RNA polymerase error rates and DNA damage, Nat Commun, vol.6, p.7972, 2015.

N. A. Dallas, Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition, Cancer Res, vol.69, pp.1951-1958, 2009.

M. Stadler, Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells, Sci Rep, vol.8, p.1151, 2018.

S. Lamouille, J. Xu, and R. Derynck, Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol, vol.15, pp.178-96, 2014.

M. Canel, A. Serrels, M. C. Frame, and V. G. Brunton, E-cadherin-integrin crosstalk in cancer invasion and metastasis
DOI : 10.1242/jcs.100115
URL : http://jcs.biologists.org/content/joces/126/2/393.full.pdf

Y. Fu, Antioxidants decrease the apoptotic effect of 5-Fu in colon cancer by regulating Src-dependent caspase-7 phosphorylation, Cell Death Dis, vol.5, p.983, 2014.

C. Focaccetti, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes, Cell Cycle, vol.10, p.115686, 2015.
DOI : 10.1371/journal.pone.0115686
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0115686&type=printable

X. Guo, Cell cycle perturbation and acquired 5-fluorouracil chemoresistance, Anticancer Res, vol.28, pp.9-14, 2008.

T. Tadano, MicroRNA-320 family is downregulated in colorectal adenoma and affects tumor proliferation by targeting CDK6, World J Gastrointest Oncol, vol.8, pp.532-574, 2016.
DOI : 10.4251/wjgo.v8.i7.532
URL : https://doi.org/10.4251/wjgo.v8.i7.532

Y. Peng, Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients, PLoS One, vol.8, p.76693, 2013.

L. Anders, A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells, Cancer Cell, vol.20, pp.620-634, 2011.

T. Moro, Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5, J Cell Physiol, vol.204, pp.927-933, 2005.

H. Lu, D. J. Chang, B. Baratte, L. Meijer, and U. Schulze-gahmen, Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin, J Med Chem, vol.48, pp.737-743, 2005.

S. Holder, Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase

N. S. Magnuson, Z. Wang, G. Ding, and R. Reeves, Why target PIM1 for cancer diagnosis and treatment?

S. C. Gupta, Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy, Antioxid Redox Signal, vol.16, pp.1295-322, 2012.

M. Du, K. He, G. Qin, J. Chen, and J. Li, Adriamycin resistance-associated prohibitin gene inhibits proliferation of human osteosarcoma MG63 cells by interacting with oncogenes and tumor suppressor genes, Oncol Lett, vol.12, 1994.

F. A. Dick and S. M. Rubin, Molecular mechanisms underlying RB protein function, Nat Rev Mol Cell Biol, vol.14, pp.297-306, 2013.

S. K. Singh, S. Banerjee, E. P. Acosta, J. W. Lillard, and R. Singh, Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21&lt

, WAF1/CIP1</sup> and p27^KIP1 pathway, Oncotarget, vol.8, pp.17216-17228, 2017.

A. Wiegering, Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin, Neoplasia, vol.19, pp.301-309, 2017.

T. Li, Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence, Cell, vol.149, pp.1269-83, 2012.

M. Kiedrowski and A. Mroz, The effects of selected drugs and dietary compounds on proliferation and apoptosis in colorectal carcinoma, Contemp Oncol, vol.18, pp.222-228, 2014.

C. Q. Xie, Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549/Taxol cells via modulation of MAPK and PI3K/Akt signaling pathways, Oncol Lett, vol.12, pp.3586-3590, 2016.

V. Yadav, P. Varshney, S. Sultana, J. Yadav, and N. Saini, Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation, BMC Cancer, vol.15, p.581, 2015.

L. Zhang, Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a, Int J Mol Med, vol.36, pp.957-66, 2015.

R. S. Nho and P. Hergert, FoxO3a and disease progression, World J Biol Chem, vol.5, p.346, 2014.

B. Cautain, Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling, PLoS One, vol.11, p.167491, 2016.

T. P. Das, S. Suman, H. Alatassi, M. K. Ankem, and C. Damodaran, Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer, Cell Death Dis, vol.7, pp.2111-2111, 2016.

A. L. Rinkenbaugh and A. S. Baldwin, The NF-?B Pathway and Cancer Stem Cells, Cells, vol.5, 2016.

V. Ruiz-de-porras, Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-?B signalling pathway, Sci Rep, vol.6, p.24675, 2016.

W. Li, C. Chen, Z. Liu, and B. Hua, Targeting Signal Transducer and Activator ofTranscription 3 for Colorectal Cancer Prevention and Treatment with Natural Products, Cancer Transl Med, vol.2, p.48, 2016.

T. Samuel, K. Fadlalla, D. N. Gales, B. D. Putcha, and U. Manne, Variable NF-?B pathway responses in colon cancer cells treated with chemotherapeutic drugs, BMC Cancer, vol.14, p.599, 2014.

J. Shin, J. Kim, S. K. Lee, H. Chae, and J. Kang, LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells, BMC Cancer, vol.10, p.425, 2010.

M. I. Körber, A. Staribacher, I. Ratzenböck, G. Steger, and R. M. Mader, NF?B-Associated Pathways in Progression of Chemoresistance to 5-Fluorouracil in an In Vitro Model of Colonic Carcinoma, Anticancer Res, vol.36, pp.1631-1640, 2016.

Y. Kang, Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NF?B survival-signaling pathway, Onco Targets Ther, vol.9, pp.7373-7384, 2016.

J. Shi and P. Wei, Interleukin-8: A potent promoter of angiogenesis in gastric cancer, Oncol Lett, vol.11, pp.1043-1050, 2016.

H. Gao, X. Lan, S. Li, and Y. Xue, Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer, Tumor Biol, vol.39, p.101042831769836, 2017.

Y. Deng, E. Verron, and R. Rohanizadeh, Molecular Mechanisms of Anti-metastatic Activity of Curcumin, Anticancer Res, vol.36, pp.5639-5648, 2016.

W. A. Hammond, A. Swaika, and K. Mody, Pharmacologic resistance in colorectal cancer: a review, Ther Adv Med Oncol, vol.8, pp.57-84, 2016.

M. M. Valenzuela, J. W. Neidigh, and N. R. Wall, Antimetabolite Treatment for Pancreatic Cancer, Chemotherapy, vol.3, 2014.

G. Housman, Drug Resistance in Cancer: An Overview, Cancers (Basel), vol.6, pp.1769-1792, 2014.

A. González-sarrías, H. Ma, M. E. Edmonds, and N. P. Seeram, Maple polyphenols, ginnalins A-C, induce S-and G2/M-cell cycle arrest in colon and breast cancer cells mediated by decreasing cyclins A and D1 levels, Food Chem, vol.136, pp.636-642, 2013.

A. De-la-cueva, Combined 5-FU and ChoK? Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts, PLoS One, vol.8, p.64961, 2013.

B. Jiang, F. Liu, Z. Liu, T. Zhang, and D. Hua, B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway, Tumor Biol, vol.37, pp.9465-9472, 2016.

A. Barve, Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats, Biopharm Drug Dispos, vol.30, pp.356-65, 2009.

L. Zhao, J. L. Au, .. Wientjes, and M. G. , Comparison of methods for evaluating drug-drug interaction, Front Biosci (Elite Ed), vol.2, pp.241-250, 2010.

K. J. Livak and T. D. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???CT Method, Methods, vol.25, pp.402-408, 2001.

J. Xia, M. J. Benner, and R. E. Hancock, NetworkAnalyst -integrative approaches for protein-protein interaction network analysis and visual exploration, Nucleic Acids Res, vol.42, pp.167-174, 2014.

K. Breuer, InnateDB: systems biology of innate immunity and beyond-recent updates and continuing curation, Nucleic Acids Res, vol.41, pp.1228-1233, 2013.

X. Wang, PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database, Nucleic Acids Res, p.45, 2017.

O. Korb, T. Stützle, and T. E. Exner, PLANTS: Application of Ant Colony Optimization to Structure-Based Drug Design, 2006.

S. Reports and |. , Influence of Protonation, Tautomeric, and Stereoisomeric States on Protein?Ligand Docking Results, J Chem Inf Model, vol.9, pp.1535-1546, 2009.

T. Brink and T. E. Exner, A combined combinatorial and pKa-based approach to ligand protonation states, J Cheminform, vol.2, p.43, 2010.